Total Payments
$671.23
2024 Payments
$23.15
Companies
19
Transactions
43
Medicare Patients
1,850
Medicare Billing
$499,454
Payment Breakdown by Category
Food & Beverage$628.02 (93.6%)
Education$43.21 (6.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $628.02 | 34 | 93.6% |
| Education | $43.21 | 9 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $112.50 | 1 | $0 (2017) |
| Genentech USA, Inc. | $88.27 | 5 | $0 (2019) |
| Keryx Biopharmaceuticals, Inc. | $78.48 | 5 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $53.52 | 4 | $0 (2018) |
| Horizon Pharma plc | $53.11 | 3 | $0 (2018) |
| Daiichi Sankyo Inc. | $36.55 | 2 | $0 (2017) |
| Travere Therapeutics, Inc. | $29.31 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $28.60 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $27.37 | 2 | $0 (2018) |
| OPKO Pharmaceuticals, LLC | $26.21 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.15 | 6 | Travere Therapeutics, Inc. ($23.15) |
| 2023 | $6.16 | 2 | Travere Therapeutics, Inc. ($6.16) |
| 2019 | $58.44 | 4 | Genentech USA, Inc. ($19.07) |
| 2018 | $139.73 | 10 | Horizon Pharma plc ($34.38) |
| 2017 | $443.75 | 21 | Lilly USA, LLC ($112.50) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 07/11/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 02/20/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $7.98 | General |
| 02/20/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 02/20/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $1.31 | General |
| 02/16/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $5.32 | General |
| 11/15/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 10/04/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/29/2019 | Ascensia Diabetes Care US Inc. | — | Education | In-kind items and services | $13.90 | General |
| 04/18/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: KRYSTEXXA | ||||||
| 04/17/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $7.07 | General |
| Category: NEPHROLOGY | ||||||
| 02/06/2019 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: BioOncology/Immunology | ||||||
| 12/20/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Cardiovascular | ||||||
| 11/08/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: NEPHROLOGY | ||||||
| 09/13/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: NEPHROLOGY | ||||||
| 06/26/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: KRYSTEXXA | ||||||
| 06/05/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: KRYSTEXXA | ||||||
| 03/16/2018 | NxStage Medical, Inc. | System One (Device) | Food and Beverage | Cash or cash equivalent | $17.06 | General |
| Category: Nephrology | ||||||
| 03/14/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: Gout/Rheumatology | ||||||
| 03/07/2018 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: BioOncology/Immunology | ||||||
| 01/18/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/10/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: Gout/Rheumatology | ||||||
| 12/15/2017 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: KRYSTEXXA | ||||||
| 11/20/2017 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Nephrology | ||||||
| 10/26/2017 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: BioOncology/Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 370 | 890 | $273,454 | $96,668 |
| 2022 | 8 | 457 | 1,105 | $308,134 | $120,176 |
| 2021 | 9 | 466 | 1,152 | $315,643 | $132,988 |
| 2020 | 11 | 557 | 1,397 | $373,441 | $149,623 |
Total Patients
1,850
Total Services
4,544
Medicare Billing
$499,454
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 27 | 166 | $91,536 | $35,845 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 354 | $74,859 | $22,006 | 29.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 15 | 95 | $52,436 | $19,125 | 36.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 165 | $24,760 | $9,654 | 39.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $8,613 | $2,696 | 31.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 29 | $6,206 | $2,442 | 39.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 18 | $5,625 | $1,842 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,215 | $1,104 | 34.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 18 | 20 | $3,088 | $1,086 | 35.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,116 | $867.71 | 27.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 24 | 163 | $84,217 | $34,377 | 40.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 25 | 142 | $73,888 | $32,104 | 43.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 87 | 259 | $36,264 | $13,630 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 116 | 210 | $37,654 | $13,454 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 221 | $40,444 | $13,373 | 33.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 23 | 42 | $16,590 | $6,410 | 38.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 33 | $12,717 | $4,653 | 36.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 20 | 23 | $3,634 | $1,275 | 35.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 12 | 12 | $2,726 | $899.44 | 33.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 33 | 184 | $94,208 | $40,899 | 43.4% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 27 | 182 | $93,002 | $40,132 | 43.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 161 | 298 | $46,383 | $19,345 | 41.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 78 | 253 | $34,408 | $13,600 | 39.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 80 | 132 | $19,906 | $9,351 | 47.0% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 14 | 25 | $9,875 | $3,756 | 38.0% |
About Dr. Christopher Keller, MD
Dr. Christopher Keller, MD is a Nephrology healthcare provider based in Caldwell, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255467312.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Keller, MD has received a total of $671.23 in payments from pharmaceutical and medical device companies, with $23.15 received in 2024. These payments were reported across 43 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($628.02).
As a Medicare-enrolled provider, Keller has provided services to 1,850 Medicare beneficiaries, totaling 4,544 services with total Medicare billing of $499,454. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Caldwell, ID
- Active Since 02/25/2007
- Last Updated 05/16/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255467312
Products in Payments
- FORTEO (Drug) $112.50
- Rituxan (Biological) $88.27
- Auryxia (Drug) $78.48
- KRYSTEXXA (Drug) $53.11
- ENTRESTO (Drug) $40.92
- INJECTAFER (Drug) $36.55
- JYNARQUE (Drug) $28.60
- ELIQUIS (Drug) $27.37
- Rayaldee (Drug) $26.21
- Veltassa (Drug) $19.61
- Uloric (Drug) $18.67
- XARELTO (Drug) $18.47
- KRYSTEXXA (Biological) $18.40
- System One (Device) $17.06
- NORTHERA (Drug) $13.40
- AFINITOR (Drug) $12.60
- BYSTOLIC (Drug) $10.73
- AURYXIA (Drug) $7.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.